Related Experiment Video
Updated: Jul 6, 2026
06:55
Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Risk-based capital requirements may be a boon to capitation
Capitation Management Report
|October 2, 2001
Summary
Capitation models remain viable, particularly when state regulations on risk-based capital requirements enhance their appeal. Explore the financial implications and strategic advantages of capitation in healthcare finance.
Area of Science:
- Healthcare Finance
- Health Economics
- Health Policy
Background:
- Capitation models are a common reimbursement strategy in healthcare.
- State-specific risk-based capital requirements can influence the financial viability of healthcare providers.
- Understanding these regulatory impacts is crucial for financial planning.
Purpose of the Study:
- To re-evaluate the attractiveness of capitation models in light of state-imposed risk-based capital requirements.
- To analyze the financial implications of these regulatory demands on capitation.
- To provide insights into the strategic financial considerations for healthcare organizations.
Main Methods:
- Financial modeling to assess capitation scenarios.
- Analysis of state-specific risk-based capital regulations.
- Comparative analysis of financial outcomes under different regulatory environments.
Main Results:
- State-imposed risk-based capital requirements can create favorable conditions for capitation.
- The financial attractiveness of capitation is significantly influenced by regulatory capital demands.
- Specific numerical outcomes demonstrate the impact of these requirements.
Conclusions:
- Capitation models should not be dismissed prematurely due to regulatory factors.
- Risk-based capital requirements can enhance the financial feasibility of capitation.
- Healthcare organizations should consider these regulatory dynamics in their financial strategies.
Related Concept Videos
01:15Methods of Documentation VI: Case Management Model
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
For example, a patient with a chronic illness...
01:30Health Information Technology and Healthcare Information System
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:12Relative Risk
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
01:20Actuarial Approach
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...